CNBC traders said acquisitions are becoming a primary route for drugmakers to enter advanced weight-loss therapy pipelines. ・One trader called it “almost a foregone conclusion” that Viking and ...

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a ...

Viking Therapeutics climbs after it completes enrollment in the second phase III obesity study for VK2735 and advances its bid in a fast-growing, competitive weight-loss market.

In the latest close session, Viking Therapeutics, Inc. (VKTX) was up +2.19% at $35.01. The stock exceeded the S&P 500, which registered a gain of 1.02% for the day. At the same time, the Dow added ...

Investors in Viking Therapeutics Inc (Symbol: VKTX) saw new options begin trading this week, for the December 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in General Motors Co (Symbol: GM), where a total of 73,915 contracts have traded so far, ...

Viking Therapeutics Inc. (NASDAQ:VKTX) is one of the 10 most shorted biotech stocks to buy according to hedge funds. On February 12, Michael Ulz from Morgan Stanley reduced his price target on Viking ...

Viking Therapeutics Inc. (NASDAQ:VKTX) is one of Jim Cramer’s Hottest GLP-1 and Weight Loss Stock Picks. Viking Therapeutics Inc. (NASDAQ:VKTX) is a biotechnology company developing treatments that ...

Investors with a lot of money to spend have taken a bullish stance on Viking Therapeutics (NASDAQ:VKTX). And retail traders should know. We noticed this today when the positions showed up on publicly ...

Viking posted a loss of $1.38 per share, worse than the 89 cent loss analysts were expecting. Last quarter, the company only missed on EPS by 13 cents, according to Benzinga Pro. The miss was driven ...